Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 25. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_1451ReovirusReoT3DRNAReoviridaeNoneYesNoNoNCIHuman NSCLC cell lineHOP-92NANAXTT assayLog10 pfu/cell30% cell survived 48 hours after post infectionNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1454ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (38.50 +/- 16.01 micromolar, 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.144 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1460ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (38.50 +/- 16.01 micromolar, 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.295NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1466ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (38.50 +/- 16.01 micromolar, 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.613NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1472ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (38.50 +/- 16.01 micromolar, 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.178 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1478ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (38.50 +/- 16.01 micromolar, 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.420NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1484ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (38.50 +/- 16.01 micromolar, 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.994NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1490ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (6.82+/- 3.22, ratio is 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.352NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1496ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (6.82+/- 3.22, ratio is 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell75% death at CI value 0.325NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1502ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (6.82+/- 3.22, ratio is 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.500NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1508ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (6.82+/- 3.22, ratio is 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.053NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1514ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (6.82+/- 3.22, ratio is 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell75% death at CI value 0.099NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1520ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (6.82+/- 3.22, ratio is 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.195NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1526ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.83+/- 0.61, 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.372NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1532ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.83+/- 0.61, 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell75 % cell death at CI 0.117NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1538ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.83+/- 0.61, 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.047NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1544ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.83+/- 0.61, 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.099NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1550ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.83+/- 0.61, 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.110NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1556ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.83+/- 0.61, 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.127NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1562ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(48.40+/-23.08, 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 1.749NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1568ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(48.40+/-23.08, 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 7.049NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1574ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(48.40+/-23.08, 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1580ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(48.40+/-23.08, 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.133NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1586ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(48.40+/-23.08, 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 1.256NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1592ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(48.40+/-23.08, 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 11.922NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950